Evidence map›Paper›PMID 39324798›Full record

ArticleAntimicrobial agents and chemotherapy2024

Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy.

Emily Puumala, Sunna Nabeela, Christopher C Thornburg, Tanja Grkovic, Priya Uppuluri, Luke Whitesell, Barry R O'Keefe, Nicole Robbins, Leah E Cowen

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emily PuumalaDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0009-0008-3371-5877
Sunna NabeelaDivision of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.
Christopher C ThornburgNatural Products Support Group, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Tanja GrkovicNatural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, USA.
Priya UppuluriDivision of Infectious Diseases, The Lundquist Institute for Biomedical Innovation at Harbor-University of California Los Angeles Medical Center, Torrance, California, USA.ORCID 0000-0002-5889-054X
Luke WhitesellDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Barry R O'KeefeNatural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, Maryland, USA.
Nicole RobbinsDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Leah E CowenDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.ORCID 0000-0001-5797-0110

Funding

NCI Program for Natural Products Discovery - CuresZIABC011854 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OKEEFE, BARRY · 2020 to 2025
$5.2M
Targeting the regulatory mechanism of hyphae to lateral yeast growth as a novel therapeutic approach against candidiasisR01AI141794 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI UPPULURI, PRIYA · 2019 to 2022
$1.5M
Canadian Government | Canadian Institutes of Health Research (CIHR) FDN-154288CCR NIH HHS HHSN261200800001CHHS | National Institutes of Health (NIH) R01AI141794HHS | NIH | National Cancer Institute (NCI) ZIA BC 011854Intramural NIH HHS ZIA BC011854NCI NIH HHS HHSN261200800001ENIAID NIH HHS R01 AI141794
6 · The paper itself

Abstract

Fungal disease affects over a billion people worldwide. Naamidine A inhibits the growth of diverse fungal pathogens through an unknown mechanism. Here, we show that the supplementation of medium with excess zinc abolishes the antifungal activity of naamidine A. Furthermore, we highlight that naamidine A has

Indexed as

Administration, TopicalAntifungal AgentsMicrobial Sensitivity TestsZincAnimalsArthrodermataceaeDermatomycosesDisease Models, AnimalDrug Resistance, FungalHumansMiceTerbinafineTineaTrichophytonAntifungal AgentsTerbinafineZincCandida albicansdermatomycosisdrug-resistantmetal chelationnatural productTrichophytonzinc

Identifiers

PMID39324798
PMCPMC11539223

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.